Generally, you can count on drugmakers for a steady revenue performance -- since patients need their medicines, revenue holds ...
There’s a little problem, though: most of the decline in the seven comes down to one company. Apple is down 14 per cent since ...
U.S. drugmaker Pfizer PFE.N is going “all in” to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Executive Officer Albert Bourla said at the JPMorgan ...
Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on ...
Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new drug last month and ...
Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...
The Wabash Valley Community Foundation has landed a $6.5 million grant toward an $11.3 million modernization and renovation of the YMCA in Terre Haute.
A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.
Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...
Bank of America Securities added Booz Allen Hamilton Holding Corp. ( NYSE: BAH) and Datadog Inc. ( DDOG) to its US 1 List, renewing Apple Inc. ( AAPL ), and removing Eli Lilly & Co. ( LLY ).
As generative AI continues to reshape the legal and corporate landscapes, actionable steps should now be at the forefront of crisis communication plans to help firms combat the rapid spread of ...
In a report released yesterday, Akash Tewari from Jefferies maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price ...